Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide

Pharmacological Reports

Volumn 64, Issue 5, 2012, Pages 1189-1199

  Song, Xiuming ^a   Chen, Yan ^a   Sun, Yajing ^a   Lin, Biqi ^b   Qin, Yansu ^a   Hui, Hui ^a   Li, Zhiyu ^a   You, Qidong ^a   Lu, Na ^a   Guo, Qinglong ^a  

^a China Pharmaceutical University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Lipopolysaccharide; Oroxylin A; Scutellaria baicalensis Georgi (Lamiaceae); Toll like receptor 4 (TLR4)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OROXYLIN A; SCUTELLARIA BAICALENSIS EXTRACT; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHORIOALLANTOIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PLANT ROOT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

EID: 84873713038     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70915-5     Document Type: Article

References (25)

1. Berger AC, Wang XQ, Zalatoris A, Cenna J, Watson JC: A murine model of ex vivo angiogenesis using aortic disks grown in fibrin clot. Microvasc Res, 2004, 68, 179-187. (Pubitemid 40288114)
2. Bonnet CS, Walsh DA: Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford), 2005, 44, 7-16. (Pubitemid 40136474)
3. Chen Y, Yang L, Lee TJ: Oroxylin A inhibition of lipopolysaccharide- induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem Pharmacol, 2000, 59, 1445-1457. (Pubitemid 30177363)
4. Clavel G, Valvason C, Yamaoka K, Lemeiter D, Laroche L, Boissier MC, Bessis N: Relationship between angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw, 2006, 17, 202-210.
5. Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, Lynch C, Bouchier-Hayes D et al.: Lipopoly-saccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer, 2002, 101, 415-422.
6. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA: Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum, 2003, 48, 2173-2177. (Pubitemid 36959197)
7. Huang WH, Chien PY, Yang CH, Lee AR: Novel synthesis of flavonoids of Scutellaria baicalensis Georgi. Chem Pharm Bull (Tokyo), 2003, 51, 339-340. (Pubitemid 41701971)
8. Ichihara E, Kiura K, Tanimoto M: Targeting angiogenesis in cancer therapy. Acta Med Okayama, 2011, 65, 353-362.
9. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest, 1973, 52, 2745-2756.
10. Kobayashi H, Lin PC: Angiogenesis links chronic inflammation with cancer. Methods Mol Biol, 2009, 511, 185-191.
11. Li C, Lin G, Zuo Z: Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos, 2011, 32, 427-445.
12. Li HN, Nie FF, Liu W, Dai QS, Lu N, Qi Q, Li ZY et al.: Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology, 2009, 257, 80-85.
13. Lu N, Yang Y, You QD, Ling Y, Gao Y, Gu HY, Zhao L et al.: Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. Cancer Lett, 2007, 258, 80-89. (Pubitemid 47600491)
14. Lu YC, Yeh WC, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine, 2008, 42, 145-151.
15. Lu ZJ, Lu N, Li CL, Li F, Zhao K, Lin B, Guo QL: Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. Toxicol Lett, 2012, 209, 211-220.
16. Makela SM, Osterlund P, Julkunen: TLR ligands induce synergistic interferon-beta and interferon-lambda1 gene expression in human monocyte-derived dendritic cells. Mol Immunol, 2011, 48, 505-515.
17. Mazibrada J, Ritta M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, Ciotti M et al.: Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol, 2008, 108, 112-120. (Pubitemid 350299432)
18. Min JK, Han KY, Kim EC, Kim YM, Lee SW, Kim OH, Kim KW et al.: Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res, 2004, 64, 644-651.
19. Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F, Karsan A: Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. Blood, 2003, 102, 1740-1742. (Pubitemid 37022568)
20. Risau W: Mechanisms of angiogenesis. Nature, 1997, 386, 671-674.
21. Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A et al.: VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology, 2009, 136, 585-595.
22. Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P, Karawajew L et al.: Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood, 1996, 87, 2805-2814. (Pubitemid 26102230)
23. Sherer DM, Abulafia O: Angiogenesis during implantation, and placental and early embryonic development. Placenta, 2001, 22, 1-13. (Pubitemid 32124091)
24. Shih HC, Hsu CS, Yang LL: In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root. J Biomed Sci, 2009, 16, 27.
25. Sun Y, Lu N, Ling Y, Gao Y, Chen Y, Wang L, Hu R et al.: Oroxylin A suppresses invasion through downregulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. Eur J Pharmacol, 2009, 603, 22-28.